New injection tested for stubborn sinus problems
NCT ID NCT06691113
Summary
This study is testing an investigational drug called itepekimab to see if it can reduce sinus inflammation and improve symptoms in adults with chronic sinusitis who don't have nasal polyps. About 60 participants will receive either itepekimab or a placebo injection for 24 weeks while continuing their standard nasal spray. Researchers will use CT scans and daily symptom diaries to measure changes in sinus swelling and symptoms like congestion and facial pressure.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC RHINOSINUSITIS WITHOUT NASAL POLYPS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Advanced Research Associates (ARA) Professionals- Site Number : 8400002
Miami, Florida, 33176, United States
-
Alamo ENT Associates- Site Number : 8400026
San Antonio, Texas, 78258, United States
-
Allervie Clinical Research - Birmingham- Site Number : 8400006
Birmingham, Alabama, 35209, United States
-
Azienda Ospedaliero-Universitaria Pisana-Site Number : 3800003
Pisa, 56124, Italy
-
ENT Associates of Texas - McKinne- Site Number : 8400013
McKinney, Texas, 75070, United States
-
Eastern Virginia Medical School (EVMS) Medical Group- Site Number : 8400007
Norfolk, Virginia, 23510, United States
-
Fondazione Policlinico Universitario Agostino Gemelli IRCCS-Site Number : 3800001
Rome, Roma, 00168, Italy
-
Fondazione Policlinico Universitario Campus Bio-Medico-Site Number : 3800002
Rome, Roma, 00128, Italy
-
Investigational Site Number : 0320001
Buenos Aires, 1425, Argentina
-
Investigational Site Number : 0320003
San Miguel de Tucumán, Tucumán Province, 4000, Argentina
-
Investigational Site Number : 0320004
Corrientes, 3400, Argentina
-
Investigational Site Number : 0560001
Leuven, 3000, Belgium
-
Investigational Site Number : 0560002
Ghent, 9000, Belgium
-
Investigational Site Number : 0560003
Brussels, 1200, Belgium
-
Investigational Site Number : 0560004
Gesves, 5340, Belgium
-
Investigational Site Number : 1240001
Québec, Quebec, G1V 4G5, Canada
-
Investigational Site Number : 1240002
Montreal, Quebec, H4A 3J1, Canada
-
Investigational Site Number : 1240003
Québec, Quebec, G1V 4W2, Canada
-
Investigational Site Number : 1240005
London, Ontario, N6A 4V2, Canada
-
Investigational Site Number : 1240009
Trois-Rivières, Quebec, G8T 7A1, Canada
-
Investigational Site Number : 1240012
Québec, Quebec, G2J 0C4, Canada
-
Investigational Site Number : 1520001
Santiago, Reg Metropolitana de Santiago, 7500505, Chile
-
Investigational Site Number : 1520002
Concepción, Región del Biobío, 4070094, Chile
-
Investigational Site Number : 1520003
Santiago, Reg Metropolitana de Santiago, 7500692, Chile
-
Investigational Site Number : 1560001
Beijing, 100730, China
-
Investigational Site Number : 1560002
Shanghai, 200127, China
-
Investigational Site Number : 1560003
Zibo, 255036, China
-
Investigational Site Number : 1560004
Baotou, 014040, China
-
Investigational Site Number : 2500004
Marseille, 13005, France
-
Investigational Site Number : 2500005
Montpellier, 34295, France
-
Investigational Site Number : 2500010
Poitiers, 86021, France
-
Investigational Site Number : 2500012
La Rochelle, 17019, France
-
Investigational Site Number : 4100001
Seoul, Seoul-teukbyeolsi, 07061, South Korea
-
Investigational Site Number : 4100002
Seoul, Seoul-teukbyeolsi, 06351, South Korea
-
Investigational Site Number : 4100003
Seoul, Seoul-teukbyeolsi, 03080, South Korea
-
Investigational Site Number : 4100004
Seoul, Seoul-teukbyeolsi, 03722, South Korea
-
Investigational Site Number : 4100005
Cheonan-si, Chungcheongnam-do, 31116, South Korea
-
Investigational Site Number : 6160001
Warsaw, Masovian Voivodeship, 00-909, Poland
-
Investigational Site Number : 6160002
Poznan, Greater Poland Voivodeship, 60-693, Poland
-
Investigational Site Number : 6160004
Bielsko-Biala, Silesian Voivodeship, 43-300, Poland
-
Investigational Site Number : 6160006
Krakow, Lesser Poland Voivodeship, 31-513, Poland
-
Investigational Site Number : 6160008
Lodz, Lódzkie, 90-302, Poland
-
Investigational Site Number : 6200001
Guimarães, 4800-055, Portugal
-
Investigational Site Number : 6200002
Porto, 3814-501, Portugal
-
Investigational Site Number : 6420001
Brasov, 500283, Romania
-
Investigational Site Number : 6420002
Bucharest, 022328, Romania
-
Investigational Site Number : 7240001
Seville, Sevilla, 41009, Spain
-
Investigational Site Number : 7240002
L'Hospitalet de Llobregat, Catalunya [Cataluña], 08907, Spain
-
Investigational Site Number : 7240003
Barcelona, Barcelona [Barcelona], 08003, Spain
-
Investigational Site Number : 7240004
Jerez de la Frontera, Cádiz, 11407, Spain
-
Investigational Site Number : 7240005
Pamplona, Navarre, 31008, Spain
-
Investigational Site Number : 7240006
Madrid, 28040, Spain
-
Modena Allergy + Asthma- Site Number : 8400005
La Jolla, California, 92037, United States
-
Sacramento Ear Nose & Throat - Roseville- Site Number : 8400008
Roseville, California, 95661, United States
-
Treasure Valley Medical Research- Site Number : 8400022
Boise, Idaho, 83706, United States
-
United Medical Doctors - Murrieta- Site Number : 8400001
Murrieta, California, 92563, United States
-
Western States Clinical Research- Site Number : 8400009
Wheat Ridge, Colorado, 80033, United States
Conditions
Explore the condition pages connected to this study.